ClearSeq Comprehensive Cancer
RUO
The ClearSeq Comprehensive Cancer targets 151 key genes associated with a wide range of cancers, including breast, lung, colorectal, and AML. This panel was developed in collaboration with cancer researchers from Washington University in St Louis, and is designed for deep coverage of target bases for confident variant detection.
The ClearSeq Comprehensive Cancer is compatible with the SureSelect Target Enrichment System, with options of post-capture and pre-capture pooling available.
The ClearSeq Comprehensive Cancer is compatible with the SureSelect Target Enrichment System, with options of post-capture and pre-capture pooling available.
For Research Use Only. Not for use in diagnostic procedures.
- Cancer
No data to display
This product is not available for purchase by the general public.
Product Details
Features
- Content provided by cancer researchers from Washington University in St. Louis
- Deep coverage of targets enabling accurate variant detection, even in FFPE tissue
- Compatible with robust SureSelect Target Enrichment workflows with pre-capture and post-capture pooling options
- Simplified NGS data analysis with SureCall software
Specifications
| Number of Genes Targeted |
|
| Number of Reactions |
|
| Targeted Genes |
|
| Tissue Sample Type |
|
Literature
- Flyers
-
ClearSeq Comprehensive Cancer Data Sheet 5991-5573EN
The research panel provides excellent performance even with challenging samples like formalin-fixed, paraffin-embedded (FFPE) DNA
- Flyers
- English
- 13 Jul 2016
- 89.68 KB
Videos
Related Products
Promotions